comparemela.com

Page 26 - கிட்நீ நோய்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lung Ultrasound Can Efficiently Diagnose Volume Overload in Hemodialysis Patients

Lung Ultrasound Can Efficiently Diagnose Volume Overload in Hemodialysis Patients
itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.

Tiny implant cures diabetes in mice

Mitotherapeutix Awarded $2 2 Million SBIR Grant from the National Institutes of Health for siRNA NASH Candidates

Mitotherapeutix Awarded $2.2 Million SBIR Grant from the National Institutes of Health for siRNA NASH Candidates Share Article FARMINGTON, Conn. (PRWEB) June 04, 2021 Mitotherapeutix LLC (MITO), a pre-clinical stage company focused on siRNA drug discovery and development based on suppression of the mitochondrial regulator MCJ (DnaJC15), today announced that it has been awarded a multi-year $2.2 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health. MITO will deploy the funds to continue IND enabling activities for siRNA candidates intended to be a novel treatment for Nonalcoholic Steatohepatitis (NASH). “NASH remains a significant unmet medical need affecting up to 5% of all adults in the United States, according to the Liver Foundation,” said Jack Talley, Chief Executive Officer, MITO. “Our novel GalNAc conjugated-siRNA candidates are being advanced towards IND fili

Global Plant-based Vaccines Market to Surpass US$ 584 1 Million by 2028, Says Coherent Market Insights (CMI)

: Key trends in the market include increasing research and development activities, increasing cases of influenza, ongoing clinical trials on plant-based vaccine, inorganic activities such as collaborations by the market players, and others. Increasing number of research and development activities for improving the effectiveness of plant-based vaccines is expected to bolster growth of the plant-based vaccines market. For instance, on November 10, 2020, Medicago Inc. started conducting clinical trials for the production of plant-based COVID-19 vaccine. The company is planning to initiate Phase II/ III clinical trial after receiving positive results from the Phase I trial. Moreover, Medicago Inc. is also developing VLP Quadrivalent plant-based vaccine for Seasonal Influenza. Currently, the influenza vaccine is in Phase II of the clinical trial. In both the cases, Nicotiana Benthamiana, an Australian tobacco plant, is used for the production of COVID-19 and Influenza vaccine.

Bluthochdruck: Wie misst man ihn korrekt und was sind die Risikofaktoren?

Bluthochdruck: Wie misst man ihn korrekt und was sind die Risikofaktoren?
welt.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from welt.de Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.